Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc

Bullboard Posts

Comment by RetailRubeon Feb 13, 2010 5:17pm

262 Views

Post# 16783666

RE: Everybody pay attention.....

Your post says we have $16.5 million in the bank, so we can do the tests without the share issue.

But when I looked at the most recent financial statements (Sept 30, 2009), it says we have $3.1 million in the bank, a $2.3 million longterm debt (Growthworks promissory note?).

If we turn this down, where will the funding come from? A rights issue? Do you have the cash?

And why did you wait until now to fight the offer? The deal has been on the table since December. Your posts have been relentlessly positive until now.

Bullboard Posts

The investment impact of the U.S. 25% tariff on Canadian imports